CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C102. A total of 10 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $44,000 | -70.7% | 94,970 | -67.7% | 0.00% | – |
Q2 2019 | $150,000 | +92.3% | 293,691 | +281.7% | 0.00% | – |
Q1 2019 | $78,000 | +66.0% | 76,948 | +247.2% | 0.00% | – |
Q4 2018 | $47,000 | -77.3% | 22,162 | -49.1% | 0.00% | – |
Q3 2018 | $207,000 | -52.8% | 43,532 | -29.1% | 0.00% | – |
Q2 2018 | $439,000 | +1.2% | 61,429 | -9.6% | 0.00% | – |
Q1 2018 | $434,000 | +387.6% | 67,962 | +432.5% | 0.00% | – |
Q4 2017 | $89,000 | -11.9% | 12,764 | 0.0% | 0.00% | – |
Q3 2017 | $101,000 | – | 12,764 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEUTSCHE BANK AG\ | 500 | $4,000 | 0.00% |
CITIGROUP INC | 2,800 | $23,000 | 0.00% |
MORGAN STANLEY | 9,864 | $80,000 | 0.00% |
Psagot Value Holdings Ltd. | 186 | $1,000 | 0.00% |
Tower Research Capital LLC (TRC) | 300 | $2,000 | 0.00% |
UBS Group AG | 1,786 | $14,000 | 0.00% |